Nonmedical use of ADHD stimulants by adults is frequently motivated by a desire to improve concentration or stay alert and is often associated with other substance use disorders.

GLP-1 receptor agonists may lower the likelihood of psychiatric treatment intensification in patients with type 2 diabetes and depression.

Among patients with cardiovascular disease, wearable devices and smartphones are effective for increasing physical activity.

The American College of Physicians offers recommendations for the pharmacologic treatment of overweight and obesity in adults.

A single dose of DT120 orally disintegrating tablets significantly improved depression severity in adults with major depressive disorder compared with placebo.

The FDA approved a new, over-the-counter intranasal naloxone spray for the treatment of emergency opioid overdose. HealthDay News — The U.S. Food and Drug Administration has approved another ...

Childhood inattentive ADHD symptoms are associated with adverse occupational outcomes and higher stress levels in adulthood.

Nitrogen dioxide emerged as the most common air pollutant that consistently was associated with psychiatric outcomes.

The FDA has approved Amphastar's Rextovy (4mg naloxone HCl) nasal spray for over-the-counter use to treat adult and pediatric opioid overdoses.

Self-reported interpersonal trauma correlates with increased cognitive disengagement syndrome symptoms in young adolescents.

The UK will ban social media use among children and adolescents aged 16 years and younger in an effort to support youth mental health.

Between 2021 and 2024, a little over 15% of women in the US reported drinking alcohol in the past 30 days while pregnant.